Auriga Laboratories CEO Featured in Exclusive Interview With WallSt.net
August 21 2006 - 7:00AM
PR Newswire (US)
NEW YORK, Aug. 21 /PRNewswire/ -- On August 17, Philip S. Pesin,
Chief Executive Officer for Auriga Laboratories(TM), Inc.
(OTC:ARGA) (BULLETIN BOARD: ARGA) updated the investment community
in an exclusive interview with http://www.wallst.net/ . Topics
covered in the interview include an overview of the Company and the
markets it serves, recent press releases, current capitalization,
and upcoming strategic and financial milestones. To hear the
interview in its entirety, visit http://www.wallst.net/ , and click
on "Interviews." Interviews require free registration, and can be
accessed either by locating the respective company's ticker symbol
under the appropriate exchange on the left-hand column of the
"Interviews" section of the site, or by entering the respective
company's ticker symbol in the Search Archive window. About Auriga
Laboratories (TM): Auriga Laboratories(TM) is a specialty
pharmaceutical company capitalizing on high-revenue markets and
opportunities in the pharmaceutical industry through aggressive
sales, integrated marketing and advanced in-house drug development
capabilities. The Company's high-growth business model combines
acquisition of proven brand names, powerful product development
strategies and rapidly-growing national sales teams and marketing
operations. Auriga acquires valuable brand portfolios that are no
longer a strategic focus for large pharmaceutical companies, then
capitalizes on untapped marketplace opportunities through brand
extension and directed sales/marketing programs. The Company's
drug-development pipeline leverages novel material science and
advanced drug delivery technologies to produce improved
formulations of successful drug portfolio brands to further expand
markets, sales and clinical indications for proven, successful
products. Auriga plans to become a fully integrated pharmaceutical
company by acquiring its own manufacturing and development
capabilities. For more information, please visit:
http://www.aurigalabs.com/ . About WallSt.net:
http://www.wallst.net/ is owned and operated by WallStreet Direct,
Inc., a wholly owned subsidiary of Financial Media Group, Inc. The
website is a leading provider of financial news, media, tools and
community-driven applications for investors. http://www.wallst.net/
offers visitors free membership to its in-depth executive
interviews, exclusive editorial content, breaking news, and several
proprietary applications. In addition to its website, WallStreet
Direct organizes investor conferences, publishes a newspaper, and
provides multimedia advertising solutions to small and mid-sized
publicly traded companies. We are expecting to receive one hundred
seventy five dollars from Auriga Laboratories(TM), Inc. for the
dissemination of this press release. For a complete list of our
advertisers, and advertising relationships, visit
http://www.wallst.net/disclaimer/disclaimer.asp . DATASOURCE:
WallStreet Direct, Inc. CONTACT: Nick Iyer of Digital Wall Street,
Inc., +1-800-4-WALL-ST Web site: http://www.wallst.net/
http://www.aurigalabs.com/
Copyright